Gilead Sciences (NASDAQ: GILD) announced its Q4 financial results on Tuesday afternoon. While the company ended up beating revenue expectations, Gilead's results were a little disappointing when it came to its earnings.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,